NO307707B1 - Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav - Google Patents

Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav

Info

Publication number: NO307707B1
Authority: NO; Norway
Prior art keywords: compounds; spiroazabicyclic; pharmaceutical preparations; preparations containing; pharmaceutical
Prior art date: 1994-08-24

Application number

NO970800A

Other languages

English (en)

Other versions

NO970800L (no

NO970800D0 (no

Inventor

Michael Balestra

John Charles Gordon

Ronald Conrad Griffith

Robert John Murray

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-24

Filing date

1997-02-21

Publication date

2000-05-15

1994-08-24 Priority claimed from GB9417084A external-priority patent/GB9417084D0/en

1995-03-08 Priority claimed from GBGB9504627.2A external-priority patent/GB9504627D0/en

1997-02-21 Application filed by Astra Ab filed Critical Astra Ab

1997-02-21 Publication of NO970800L publication Critical patent/NO970800L/no

1997-02-21 Publication of NO970800D0 publication Critical patent/NO970800D0/no

2000-05-15 Publication of NO307707B1 publication Critical patent/NO307707B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO970800A 1994-08-24 1997-02-21 Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav NO307707B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9417084A GB9417084D0 (en)	1994-08-24	1994-08-24	Compounds useful in therapy
GBGB9504627.2A GB9504627D0 (en)	1995-03-08	1995-03-08	Compounds for use in therapy
PCT/SE1995/000937 WO1996006098A1 (en)	1994-08-24	1995-08-22	Spiro-azabicyclic compounds useful in therapy

Publications (3)

Publication Number	Publication Date
NO970800L NO970800L (no)	1997-02-21
NO970800D0 NO970800D0 (no)	1997-02-21
NO307707B1 true NO307707B1 (no)	2000-05-15

Family

ID=26305509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970800A NO307707B1 (no)	1994-08-24	1997-02-21	Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav

Country Status (33)

Country	Link
US (2)	US5902814A (no)
EP (1)	EP0777671B1 (no)
JP (1)	JP3708962B2 (no)
KR (1)	KR100366331B1 (no)
CN (2)	CN1056846C (no)
AR (1)	AR031828A2 (no)
AT (1)	ATE192157T1 (no)
AU (1)	AU690735B2 (no)
BR (1)	BR9508751A (no)
CA (1)	CA2196995C (no)
CZ (1)	CZ289512B6 (no)
DE (1)	DE69516524T2 (no)
DK (1)	DK0777671T3 (no)
EE (1)	EE03399B1 (no)
EG (1)	EG24222A (no)
ES (1)	ES2145922T3 (no)
FI (1)	FI112868B (no)
GR (1)	GR3033878T3 (no)
HU (1)	HUT77352A (no)
IL (1)	IL115039A (no)
IS (1)	IS1852B (no)
MX (1)	MX9701292A (no)
NO (1)	NO307707B1 (no)
NZ (1)	NZ292289A (no)
PL (1)	PL183933B1 (no)
PT (1)	PT777671E (no)
RU (1)	RU2148058C1 (no)
SA (1)	SA95160370B1 (no)
SK (1)	SK282366B6 (no)
TR (1)	TR199501053A2 (no)
TW (1)	TW397837B (no)
UA (1)	UA54375C2 (no)
WO (1)	WO1996006098A1 (no)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5977144A (en) *	1992-08-31	1999-11-02	University Of Florida	Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
AR013184A1 (es) *	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
US6277870B1 (en)	1998-05-04	2001-08-21	Astra Ab	Use
SE9900100D0 (sv)	1999-01-15	1999-01-15	Astra Ab	New compounds
JP4564135B2 (ja) *	1999-07-26	2010-10-20	住友化学株式会社	高純度フェノチアジン化合物とその製造方法、およびその中間体の製造方法、並びにその中間体の原料の水和物と新規結晶
WO2001066546A1 (en) *	2000-03-09	2001-09-13	Mitsubishi Pharma Corporation	Spiro compounds, process for preparing the same and use thereof as drugs
US8914114B2 (en)	2000-05-23	2014-12-16	The Feinstein Institute For Medical Research	Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
EP1317460A4 (en) *	2000-08-28	2005-04-20	Univ Colorado State Res Found	COMPOUNDS CONTAINING OXAZOLIDINONE FRAGMENT AND USES
US6569865B2 (en)	2001-06-01	2003-05-27	Astrazeneca Ab	Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
US20040259909A1 (en) *	2001-10-16	2004-12-23	Mccarthy Dennis	Treatment of fibromyalgia syndrome
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
JP2005522457A (ja) *	2002-02-26	2005-07-28	ノースショア−ロングアイランドジューイッシュリサーチインスティチュート	脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害
SE0202598D0 (sv) *	2002-09-02	2002-09-02	Astrazeneca Ab	Alpha-7 Nicotinic receptor agonists and statins in combination
WO2004052365A2 (en) *	2002-12-06	2004-06-24	North Shore-Long Island Jewish Research Institute	Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
US7238715B2 (en) *	2002-12-06	2007-07-03	The Feinstein Institute For Medical Research	Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
CA2531510A1 (en) *	2003-07-08	2005-01-20	Astrazeneca Ab	Spiro '1-azabicyclo '2.2.2!octan-3,5'-oxazolidin-2'one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor
US10912712B2 (en)	2004-03-25	2021-02-09	The Feinstein Institutes For Medical Research	Treatment of bleeding by non-invasive stimulation
WO2005092308A2 (en) *	2004-03-25	2005-10-06	The Feinstein Institute For Medical Research	Neural tourniquet
US20080113983A1 (en) *	2004-12-15	2008-05-15	Astrazeneca Ab	Nicotinic Acetylcholine Receptor Ligands
US11207518B2 (en)	2004-12-27	2021-12-28	The Feinstein Institutes For Medical Research	Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CA2593079C (en)	2004-12-27	2014-08-19	North Shore-Long Island Jewish Research Institute	Treating inflammatory disorders by electrical vagus nerve stimulation
JP2008525524A (ja) *	2004-12-28	2008-07-17	アストラゼネカ・アクチエボラーグ	アリールスルホンアミドモジュレーター
EP2275096A3 (en)	2005-08-26	2011-07-13	Braincells, Inc.	Neurogenesis via modulation of the muscarinic receptors
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
RU2326787C2 (ru) *	2005-11-09	2008-06-20	Сергей Федорович Бокарев	Способ управления крылом, помещенным в текучую среду, при его взаимодействии с этой средой и устройство для его осуществления
US8316104B2 (en)	2005-11-15	2012-11-20	California Institute Of Technology	Method and apparatus for collaborative system
EP2255848A3 (en)	2006-09-04	2011-04-06	NeuroSearch AS	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
KR20090064418A (ko)	2006-09-08	2009-06-18	브레인셀즈 인코퍼레이션	4-아실아미노피리딘 유도체 포함 조합물
US8391970B2 (en)	2007-08-27	2013-03-05	The Feinstein Institute For Medical Research	Devices and methods for inhibiting granulocyte activation by neural stimulation
DE102008015999B4 (de)	2008-03-27	2011-04-21	Novar Gmbh	Übertragungsweg - Prüfverfahren für eine Gefahrenmeldeanlage
US9662490B2 (en)	2008-03-31	2017-05-30	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en) *	2008-03-31	2015-12-15	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US7863291B2 (en) *	2008-04-23	2011-01-04	Bristol-Myers Squibb Company	Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8309577B2 (en)	2008-04-23	2012-11-13	Bristol-Myers Squibb Company	Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
CA2728675A1 (en)	2008-06-20	2009-12-23	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof
ES2452484T3 (es)	2008-11-18	2014-04-01	Setpoint Medical Corporation	Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
PE20110711A1 (es)	2008-11-19	2011-10-11	Envivo Pharmaceuticals Inc	Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
US8996116B2 (en)	2009-10-30	2015-03-31	Setpoint Medical Corporation	Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en)	2009-05-01	2015-12-15	Setpoint Medical Corporation	Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8886339B2 (en)	2009-06-09	2014-11-11	Setpoint Medical Corporation	Nerve cuff with pocket for leadless stimulator
EP2429518A1 (en) *	2009-05-11	2012-03-21	Envivo Pharmaceuticals, Inc.	Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
US8278320B2 (en)	2009-10-28	2012-10-02	Bristol-Myers Squibb Company	Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8507516B2 (en)	2009-10-28	2013-08-13	Bristol-Myers Squibb Company	Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
US11051744B2 (en)	2009-11-17	2021-07-06	Setpoint Medical Corporation	Closed-loop vagus nerve stimulation
US9833621B2 (en)	2011-09-23	2017-12-05	Setpoint Medical Corporation	Modulation of sirtuins by vagus nerve stimulation
CN102821814B (zh)	2009-12-23	2015-07-15	赛博恩特医疗器械公司	用于治疗慢性炎症的神经刺激设备和系统
JP2013525457A (ja)	2010-04-30	2013-06-20	ブリストル−マイヤーズスクイブカンパニー	アルファ−７ニコチン性アセチルコリン受容体リガンドプロドラッグとしてのアザ−二環式アミンｎ−オキシド化合物
MX2012013345A (es)	2010-05-17	2013-02-11	Envivo Pharmaceuticals Inc	Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin- 3-il)benzo[b]tiofeno-2-carboxamida monohidratado.
WO2012154865A2 (en)	2011-05-09	2012-11-15	Setpoint Medical Corporation	Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US12172017B2 (en)	2011-05-09	2024-12-24	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
US9572983B2 (en)	2012-03-26	2017-02-21	Setpoint Medical Corporation	Devices and methods for modulation of bone erosion
RU2635522C2 (ru)	2012-05-08	2017-11-13	Форум Фармасьютикалз, Инк.	Способы поддержания, лечения или улучшения когнитивной функции
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
CN105189482A (zh)	2013-02-07	2015-12-23	武田药品工业株式会社	作为毒蕈碱m4受体激动剂的哌啶-1-基羧酸酯和氮杂卓-1-基羧酸酯
AU2014282977B2 (en)	2013-06-21	2018-06-14	Takeda Pharmaceutical Company Limited	1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
US11311725B2 (en)	2014-10-24	2022-04-26	Setpoint Medical Corporation	Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en)	2015-02-03	2016-08-11	Setpoint Medical Corporation	Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en)	2016-01-13	2020-03-24	Setpoint Medical Corporation	Systems and methods for establishing a nerve block
CN114904142A (zh)	2016-01-20	2022-08-16	赛博恩特医疗器械公司	迷走神经刺激的控制
US11471681B2 (en)	2016-01-20	2022-10-18	Setpoint Medical Corporation	Batteryless implantable microstimulators
US10314501B2 (en)	2016-01-20	2019-06-11	Setpoint Medical Corporation	Implantable microstimulators and inductive charging systems
US10583304B2 (en)	2016-01-25	2020-03-10	Setpoint Medical Corporation	Implantable neurostimulator having power control and thermal regulation and methods of use
US10661112B2 (en)	2016-07-25	2020-05-26	Tonal Systems, Inc.	Digital strength training
US11745039B2 (en)	2016-07-25	2023-09-05	Tonal Systems, Inc.	Assisted racking of digital resistance
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
WO2019036470A1 (en)	2017-08-14	2019-02-21	Setpoint Medical Corporation	TESTING TEST FOR STIMULATION OF NERVE WAVE
US10617903B2 (en)	2017-10-02	2020-04-14	Tonal Systems, Inc.	Exercise machine differential
US10589163B2 (en)	2017-10-02	2020-03-17	Tonal Systems, Inc.	Exercise machine safety enhancements
US10486015B2 (en)	2017-10-02	2019-11-26	Tonal Systems, Inc.	Exercise machine enhancements
US10335626B2 (en)	2017-10-02	2019-07-02	Tonal Systems, Inc.	Exercise machine with pancake motor
US11660443B2 (en)	2018-04-20	2023-05-30	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
US11260229B2 (en)	2018-09-25	2022-03-01	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US12343535B2 (en)	2019-04-12	2025-07-01	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
AU2021207815A1 (en)	2020-01-13	2022-06-23	The Feinstein Institutes For Medical Research	Treating bleeding and bleeding disorders via high intensity focused ultrasound stimulation of the spleen
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤
EP4566539A1 (en)	2020-05-21	2025-06-11	The Feinstein Institutes for Medical Research	Systems and methods for vagus nerve stimulation
US11285355B1 (en)	2020-06-08	2022-03-29	Tonal Systems, Inc.	Exercise machine enhancements
US11878204B2 (en)	2021-04-27	2024-01-23	Tonal Systems, Inc.	First repetition detection
US11998804B2 (en)	2021-04-27	2024-06-04	Tonal Systems, Inc.	Repetition phase detection
WO2022245878A1 (en)	2021-05-17	2022-11-24	Setpoint Medical Corporation	Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4028351A (en) *	1971-09-07	1977-06-07	Buskine S.A.	Method for the preparation of derivatives of spiro (4,5)-decane and derivatives thus obtained
CH601304A5 (no) *	1974-02-12	1978-07-14	Buskine Sa
SU495310A1 (ru) *	1974-03-05	1975-12-15	Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе	Хинуклидил-3-диарал(гетерил) карбинолы, про вл ющие антигистаминную, антисеротониновую и антиаллергическую активность и способ их получени
GB8808433D0 (en) *	1988-04-11	1988-05-11	Merck Sharp & Dohme	Therapeutic agents
GB8816299D0 (en) *	1988-07-08	1988-08-10	Merck Sharp & Dohme	Therapeutic agents
IL97726A (en) *	1990-04-10	1994-12-29	Israel Inst Biolog Res	Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds
US5534520A (en) *	1990-04-10	1996-07-09	Fisher; Abraham	Spiro compounds containing five-membered rings
US5073560A (en) *	1990-07-20	1991-12-17	Fisons Corporation	Spiro-isoxazolidine derivatives as cholinergic agents
US5137895A (en) *	1991-04-29	1992-08-11	A. H. Robins Company, Incorporated	3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols

1995
- 1995-08-22 HU HU9701965A patent/HUT77352A/hu unknown
- 1995-08-22 NZ NZ292289A patent/NZ292289A/en not_active IP Right Cessation
- 1995-08-22 WO PCT/SE1995/000937 patent/WO1996006098A1/en not_active Ceased
- 1995-08-22 RU RU97104165A patent/RU2148058C1/ru not_active IP Right Cessation
- 1995-08-22 PL PL95318760A patent/PL183933B1/pl not_active IP Right Cessation
- 1995-08-22 DK DK95930755T patent/DK0777671T3/da active
- 1995-08-22 CZ CZ1997392A patent/CZ289512B6/cs not_active IP Right Cessation
- 1995-08-22 EE EE9700039A patent/EE03399B1/xx not_active IP Right Cessation
- 1995-08-22 CN CN95195518A patent/CN1056846C/zh not_active Expired - Fee Related
- 1995-08-22 ES ES95930755T patent/ES2145922T3/es not_active Expired - Lifetime
- 1995-08-22 CA CA002196995A patent/CA2196995C/en not_active Expired - Fee Related
- 1995-08-22 PT PT95930755T patent/PT777671E/pt unknown
- 1995-08-22 KR KR1019970701159A patent/KR100366331B1/ko not_active Expired - Fee Related
- 1995-08-22 DE DE69516524T patent/DE69516524T2/de not_active Expired - Fee Related
- 1995-08-22 AU AU34018/95A patent/AU690735B2/en not_active Ceased
- 1995-08-22 EP EP95930755A patent/EP0777671B1/en not_active Expired - Lifetime
- 1995-08-22 MX MX9701292A patent/MX9701292A/es unknown
- 1995-08-22 US US08/525,575 patent/US5902814A/en not_active Expired - Fee Related
- 1995-08-22 BR BR9508751A patent/BR9508751A/pt not_active IP Right Cessation
- 1995-08-22 AT AT95930755T patent/ATE192157T1/de not_active IP Right Cessation
- 1995-08-22 SK SK216-97A patent/SK282366B6/sk not_active IP Right Cessation
- 1995-08-22 JP JP50799596A patent/JP3708962B2/ja not_active Expired - Fee Related
- 1995-08-22 UA UA97031329A patent/UA54375C2/uk unknown
- 1995-08-23 EG EG70395A patent/EG24222A/xx active
- 1995-08-23 IL IL11503995A patent/IL115039A/xx not_active IP Right Cessation
- 1995-08-24 TW TW084108836A patent/TW397837B/zh not_active IP Right Cessation
- 1995-08-24 TR TR95/01053A patent/TR199501053A2/xx unknown
- 1995-11-08 SA SA95160370A patent/SA95160370B1/ar unknown
1997
- 1997-02-03 IS IS4424A patent/IS1852B/is unknown
- 1997-02-21 NO NO970800A patent/NO307707B1/no not_active IP Right Cessation
- 1997-02-24 FI FI970762A patent/FI112868B/fi active
1998
- 1998-11-09 US US09/188,099 patent/US6051581A/en not_active Expired - Fee Related
1999
- 1999-11-08 CN CN99123574A patent/CN1099419C/zh not_active Expired - Fee Related
2000
- 2000-04-10 AR ARP000101632A patent/AR031828A2/es unknown
- 2000-07-04 GR GR20000401563T patent/GR3033878T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
HK1010370A1 (en)	1999-06-17
EG24222A (en)	2008-11-10
HUT77352A (hu)	1998-03-30
FI112868B (fi)	2004-01-30
ES2145922T3 (es)	2000-07-16
PL183933B1 (pl)	2002-08-30
GR3033878T3 (en)	2000-11-30
DK0777671T3 (da)	2000-07-24
CZ289512B6 (cs)	2002-02-13
US6051581A (en)	2000-04-18
JPH10504561A (ja)	1998-05-06
CZ39297A3 (en)	1997-12-17
WO1996006098A1 (en)	1996-02-29
EE03399B1 (et)	2001-04-16
NO970800L (no)	1997-02-21
CN1056846C (zh)	2000-09-27
BR9508751A (pt)	1997-08-12
SK282366B6 (sk)	2002-01-07
KR100366331B1 (ko)	2003-04-10
MX9701292A (es)	1997-05-31
SA95160370B1 (ar)	2006-06-04
AU3401895A (en)	1996-03-14
IL115039A0 (en)	1995-12-08
CN1099419C (zh)	2003-01-22
EE9700039A (et)	1997-08-15
CA2196995A1 (en)	1996-02-29
IS1852B (is)	2003-02-21
TR199501053A2 (tr)	1996-06-21
SK21697A3 (en)	1997-09-10
UA54375C2 (uk)	2003-03-17
NZ292289A (en)	1998-05-27
ATE192157T1 (de)	2000-05-15
AU690735B2 (en)	1998-04-30
TW397837B (en)	2000-07-11
EP0777671B1 (en)	2000-04-26
PL318760A1 (en)	1997-07-07
EP0777671A1 (en)	1997-06-11
DE69516524T2 (de)	2001-01-18
CN1284505A (zh)	2001-02-21
CN1159808A (zh)	1997-09-17
RU2148058C1 (ru)	2000-04-27
US5902814A (en)	1999-05-11
FI970762L (fi)	1997-02-24
IL115039A (en)	2001-08-26
FI970762A0 (fi)	1997-02-24
NO970800D0 (no)	1997-02-21
AR031828A2 (es)	2003-10-08
DE69516524D1 (de)	2000-05-31
CA2196995C (en)	2008-05-13
IS4424A (is)	1997-02-03
JP3708962B2 (ja)	2005-10-19
PT777671E (pt)	2000-08-31

Publication	Publication Date	Title
NO307707B1 (no)	2000-05-15	Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO306401B1 (no)	1999-11-01	Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
NO307925B1 (no)	2000-06-19	Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater
NO20014219D0 (no)	2001-08-31	<Kappa>-agonist-forbindelser og farmasöytiske preparater derav
NO20021401D0 (no)	2002-03-20	Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO2009028I1 (no)	2014-05-19	Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
NO922506L (no)	1992-12-28	Farmasoeytiske preparat
NO943511D0 (no)	1994-09-21	Farmasöytiske preparater og anvendelse derav
DK0729956T3 (da)	2001-11-26	Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO943888D0 (no)	1994-10-14	Farmasöytisk preparat
NO308533B1 (no)	2000-09-25	Heteroarylaminer, anvendelse derav og farmasøytisk preparat
NO961274D0 (no)	1996-03-29	Azolderivat og farmasöytiske preparat derav
NO307092B1 (no)	2000-02-07	Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
NO304073B1 (no)	1998-10-19	Nye steroider, farmasöytisk preparat inneholdende disse forbindelsene og deres anvendelse
NO951447D0 (no)	1995-04-12	Organoaluminoksyprodukt, fremstilling og anvendelse
NO960722D0 (no)	1996-02-23	Benzazepinderivat, farmasöytisk preparat inneholdende dette, og mellomprodukter for dette
NO965102L (no)	1997-06-02	Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
NO934372D0 (no)	1993-12-02	Nye forbindelser og farmas!ytisk preparat derav
NO304890B1 (no)	1999-03-01	Farmas°ytiske forbindelser og farmas°ytiske preparater
NO973980D0 (no)	1997-08-29	Imiadazolderivater og medisinsk preparat
NO995838D0 (no)	1999-11-29	Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme
NO308213B1 (no)	2000-08-14	Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
NO950950D0 (no)	1995-03-13	Farmasöytisk preparat
NO307512B1 (no)	2000-04-17	Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse
NO911298D0 (no)	1991-04-03	Farmasoeytisk preparat og anvendelse derav.

Legal Events

Date	Code	Title	Description
2010-03-22	MM1K	Lapsed by not paying the annual fees